AbbVie: all 2,243 studies

Page 13 of 23. Open to participants first (136), then studies with results posted, then the rest; newest registration first within each.

• Proellex® Pharmacokinetic Bridging Study IICompletedNCT00620503Phase 1Results posted
• Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With OsteoporosisCompletedNCT00619957Phase 3Results posted
• An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With EndometriosisCompletedNCT00619866Phase 2Results posted
• A Safety and Pharmacokinetic Study of Proellex®CompletedNCT00619385Phase 1Results posted
• A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure MonitoringCompletedNCT00618956Phase 3Results posted
• Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatCompletedNCT00618722Phase 1/2Results posted
• Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatCompletedNCT00618618Phase 2Results posted
• Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00616772Phase 3Results posted
• Treatment of Moderate to Severe Facial Acne VulgarisCompletedNCT00612573Phase 2Results posted
• Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK PatientsCompletedNCT00611403Phase 2Results posted
• Phase 2 Study for the Treatment of Superficial LipomasCompletedNCT00608842Phase 2Results posted
• Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly RisedronateCompletedNCT00577720Phase 2Results posted
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)CompletedNCT00577473Phase 3Results posted
• Bone Microarchitecture in Osteopenic Postmenopausal WomenTerminatedNCT00577395Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00575016Phase 2Results posted
• Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative ColitisCompletedNCT00573794Phase 3Results posted
• A Study of 2 Doses of MAP0010 and Placebo in Asthmatic ChildrenCompletedNCT00569192Phase 3Results posted
• Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical DystoniaCompletedNCT00564681Phase 2Results posted
• Safety and Efficacy Study of Viokase® 16 for the Correction of SteatorrheaCompletedNCT00559364Phase 3Results posted
• Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic EndometriosisTerminatedNCT00556075Phase 2Results posted
• A Study of 2 Doses of MAP0010 in Adult AsthmaticsCompletedNCT00554970Phase 2Results posted
• Asacol Acute Diverticulitis(DIVA)StudyCompletedNCT00554099Phase 2Results posted
• BOTOX® Economic Spasticity Trial (BEST)CompletedNCT00549783Phase 4Results posted
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for HypertensionTerminatedNCT00547300Phase 3Results posted
• Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK SurgeryCompletedNCT00544713Not applicableResults posted
• A Study of a 35 mg Delayed Release Formulation of Risedronate for OsteoporosisCompletedNCT00541658Phase 3Results posted
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00541242Phase 4Results posted
• Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesCompletedNCT00539526Phase 4Results posted
• A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00538304Phase 2Results posted
• MDs on Botox Utility (MOBILITY)CompletedNCT00535938Results posted
• Safety and Efficacy of AGN201781 in Neuropathic PainTerminatedNCT00533351Phase 2Results posted
• Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical DystoniaCompletedNCT00528541Phase 4Results posted
• A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)CompletedNCT00524537Results posted
• A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract SurgeryCompletedNCT00524264Phase 3Results posted
• A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal FissuresCompletedNCT00522041Phase 3Results posted
• A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract SurgeryCompletedNCT00521456Phase 3Results posted
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedNCT00518089Phase 3Results posted
• Safety and Efficacy of an Artificial Tear for the Treatment of Dry EyeCompletedNCT00514852Not applicableResults posted
• Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)CompletedNCT00513682Phase 3Results posted
• Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)CompletedNCT00511706Phase 2Results posted
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedNCT00509873Phase 3Results posted
• Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaCompletedNCT00509106Phase 3Results posted
• A Comparison of Once a Day Dose Compared to 2 Doses/DayCompletedNCT00505778Phase 3Results posted
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4CompletedNCT00497146Phase 3Results posted
• Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute ManiaCompletedNCT00488618Phase 2Results posted
• A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00481091Phase 1/2Results posted
• Study of Safety and Efficacy of an Oral ContraceptiveCompletedNCT00477633Phase 3Results posted
• Effect of Memantine on Functional Communication in Patients With Alzheimer's DiseaseCompletedNCT00469456Phase 4Results posted
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal WomenCompletedNCT00467259Phase 3Results posted
• Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular EdemaCompletedNCT00464685Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial ConjunctivitisCompletedNCT00464438Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00461292Phase 3Results posted
• 24-hour IOP-lowering Effect of Brimonidine 0.1%CompletedNCT00457795Phase 4Results posted
• Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia SyndromeTerminatedNCT00445705Phase 2Results posted
• Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome PainTerminatedNCT00441766Phase 2Results posted
• Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%CompletedNCT00440011Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00439140Phase 3Results posted
• Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCompletedNCT00437658Phase 2Results posted
• Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical DystoniaTerminatedNCT00432341Phase 4Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00424190Phase 3Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00423657Phase 3Results posted
• Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)CompletedNCT00408317Phase 3Results posted
• A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular DegenerationTerminatedNCT00395057Phase 2Results posted
• Study of Safety and Efficacy of an Oral ContraceptiveCompletedNCT00391807Phase 3Results posted
• Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning MethodCompletedNCT00386360Phase 3Results posted
• Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsCompletedNCT00360568Phase 3Results posted
• Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsCompletedNCT00357994Phase 3Results posted
• A Comparison of a New Drug to Treat Overactive Bladder vs. PlaceboCompletedNCT00350636Phase 3Results posted
• Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseCompletedNCT00335153Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisCompletedNCT00333814Phase 2/3Results posted
• A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's DiseaseCompletedNCT00322153Phase 3Results posted
• Study of Milnacipran for the Treatment of FibromyalgiaCompletedNCT00314249Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00311376Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyCompletedNCT00297167Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT00284518Phase 2Results posted
• A Study of Monthly Risedronate for OsteoporosisCompletedNCT00247273Phase 3Results posted
• The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 MonthsCompletedNCT00224133Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224120Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224107Phase 3Results posted
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) PatientsCompletedNCT00224055Phase 4Results posted
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic AgentsCompletedNCT00224042Phase 4Results posted
• A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological ConditionCompletedNCT00224029Phase 4Results posted
• Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological ConditionCompletedNCT00224016Phase 4Results posted
• Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis PatientsCompletedNCT00224003Phase 4Results posted
• 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.CompletedNCT00223977Phase 2/3Results posted
• Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCompletedNCT00195663Phase 3Results posted
• A Research Study for Patients With Overactive BladderCompletedNCT00168454Phase 2Results posted
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedNCT00168428Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168389Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168337Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168324Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168298Phase 3Results posted
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedNCT00156910Phase 3Results posted
• Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic ImpactCompletedNCT00141518Phase 4Results posted
• The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive DisorderCompletedNCT00107120Phase 3Results posted
• Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in ChildrenCompletedNCT00106028Phase 3Results posted
• Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung FunctionCompletedNCT00076687Phase 2Results posted
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative ColitisCompletedNCT00073021Phase 3Results posted
• Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung CancerCompletedNCT00065429Phase 1/2Results posted
• A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult ParticipantsActive, not recruitingNCT07730554Phase 2

← AbbVie overview and focus areas